Recombinant Newcastle Disease virus Expressing IL15 Demonstrates Promising Antitumor Efficiency in Melanoma Model
/in International Publications, Malignant Melanoma, Newcastle Disease Virus /von 2014-11-24 / Technol. Cancer Res. Treat. 2015 Oct;14(5):607-15Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response
/in Dendritic Cells, Hypernephroma, International Publications, Malignant Melanoma /von 2014-09-23 / J Transl Med 2014 Sep;12:262Efficiency of dendritic cell vaccination against B16 melanoma depends on the immunization route
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-08-14 / PLoS ONE 2014;9(8):e105266Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised „proof-of-principle“ phase II study
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-07-22 / J Transl Med 2014 Jul;12:209Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-07-17 / Am. J. Ophthalmol. 2014 Nov;158(5):939-47Melanoma cell lysate induces CCR7 expression and in vivo migration to draining lymph nodes of therapeutic human dendritic cells
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-07-01 / Immunology 2014 Jul;142(3):396-405Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-02-27 / Oncoimmunology 2014 Jan;3(1):e27589Long-term complete remission following radiosurgery and immunotherapy in a melanoma patient with brain metastasis: immunologic correlates
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-02-05 / Cancer Immunol Res 2014 May;2(5):404-9Novel dendritic cell-based vaccination in late stage melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-01-01 / Hum Vaccin Immunother 2014;10(11):3132-8
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de